Skip to product information
1 of 1

GMF-β Protein, Mouse

GMF-β Protein, Mouse

Catalog Number: UA040522 Brand: UA BIOSCIENCE
Price:
Regular price $140 USD
Regular price Sale price $140 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Mouse
Synonyms Glia maturation factor beta, GMF-beta
Accession Q9CQI3
Amino Acid Sequence

Ser2-His142

Expression System E.coli
Molecular Weight

16 kDa (Reducing)

Purity >95% by SDS-PAGE and HPLC
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag No Tag
Physical Appearance Lyophilized powder
Storage Buffer

PBS, pH7.4

Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage

·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.

Reference

Trends Cell Biol. 2018 Sep;28(9):749-760.
Nat Rev Neurosci. 2015 Jun;16(6):358-72.

Background

Glia maturation factor-β (GMF-β) is a highly evolutionarily conserved protein belonging to the ADF/cofilin superfamily, first isolated from bovine brain tissue in 1972. Predominantly expressed in the central nervous system (CNS), GMF-β is also detected in various peripheral tissues including colon, thymus, and kidney. As a critical regulator of the Arp2/3 complex-mediated actin cytoskeleton remodeling, GMF-β controls branched actin content, lamellipodial dynamics, and cellular motility. Structurally, GMF-β lacks a classical signal peptide but can be secreted through non-conventional pathways, functioning as both an intracellular signaling molecule and an extracellular modulator of glial cell maturation and differentiation. Whole-body knockout studies in mice demonstrate that GMF-β deficiency is non-lethal, suggesting potential redundancy or compensation mechanisms, yet reveals marked impairments in motor performance, learning capabilities, and inflammatory responses.

Picture

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).

RP-HPLC

>95% as determined by RP-HPLC.